Skip to main content
. 2022 Sep 1;21:168. doi: 10.1186/s12933-022-01606-5

Table 3.

Associations between the TyG index and severity of CAD

Model 1 Model 2 Model 3
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
TyG index 0.825 0.559–1.216 0.331 1.398 1.197–1.633  < 0.001 1.355 1.154–1.591  < 0.001
T1 Reference Reference Reference
T2 1.268 1.025–1.569 0.029 1.330 1.061–1.668 0.013 1.283 1.024–1.607 0.031
T3 1.403 1.129–1.745 0.002 1.578 1.249–1.994  < 0.001 1.496 1.183–1.893  < 0.001

Model 1: unadjusted

Model 2: adjusted for age and sex

Model 3: adjusted for sex, age, BMI, smoking, drinking, hypertension, eGFR, antiplatelet drug use, antilipidemic drug use, and antihypertensive drug use

TyG triglyceride–glucose, CAD coronary artery disease, OR odds ratio, CI confidence interval, BMI body mass index, eGFR estimated glomerular filtration rate